Literature DB >> 1349625

Direct comparison between protons and alpha-particles of the same LET: I. Irradiation methods and inactivation of asynchronous V79, HeLa and C3H 10T1/2 cells.

D T Goodhead1, M Belli, A J Mill, D A Bance, L A Allen, S C Hall, F Ianzani, G Simone, D L Stevens, A Stretch.   

Abstract

A direct comparison was carried out of the biological effectiveness of protons and alpha-particles of the same linear energy transfer (LET) under identical conditions with a variety of in vitro biological systems. Monolayers of mammalian cells were irradiated with accelerated beams of protons (1.2 and 1.4 MeV) and alpha-particles (30 and 35 MeV) corresponding to LETs of 23 and 20 keV microns-1 for each particle type. For V79-4 cells it was observed that the linear term of the dose-response for cell inactivation by protons was significantly greater than that for alpha-particles of the same LET. For HeLa and HeLa S3 cells, also, the linear term appeared to be greater for protons, but this was not observed with more limited data for C3H 10T1/2 cells. The result for V79 cells is in agreement with the report of Belli et al. (1989) who observed that the biological effectiveness of protons rose sharply between 17 and 30 keV microns-1 in strong contrast to alpha-particles which reached a peak effectiveness at greater than 100 keV microns-1. These results place new constraints on the biologically relevant features of the microscopic structure of radiation tracks, and have implications for the mechanistic and practical comparison between radiations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349625     DOI: 10.1080/09553009214551421

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  13 in total

1.  Repair kinetic considerations in particle beam radiotherapy.

Authors:  A Carabe-Fernandez; R G Dale; H Paganetti
Journal:  Br J Radiol       Date:  2011-01-25       Impact factor: 3.039

2.  Calculation of the inactivation cross section of v79 cells by protons in radiotherapy.

Authors:  Faika A Azooz; Thamer J Alkhalidy
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12

3.  Changes in RBE of 14-MeV (d + T) neutrons for V79 cells irradiated in air and in a phantom: is RBE enhanced near the surface?

Authors:  S Schalla; C Herskind; K H Höver; W J Lorenz; E W Hahn
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

4.  Detection of heavy-ion-induced DNA double-strand breaks using static-field gel electrophoresis.

Authors:  G Taucher-Scholz; J Heilmann; M Schneider; G Kraft
Journal:  Radiat Environ Biophys       Date:  1995-06       Impact factor: 1.925

5.  Relative biological effectiveness of alpha-particle emitters in vivo at low doses.

Authors:  R W Howell; M T Azure; V R Narra; D V Rao
Journal:  Radiat Res       Date:  1994-03       Impact factor: 2.841

6.  Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative biological effectiveness of alpha-particle emitters in vivo.

Authors:  R W Howell; S M Goddu; V R Narra; D R Fisher; R E Schenter; D V Rao
Journal:  Radiat Res       Date:  1997-03       Impact factor: 2.841

Review 7.  Assessing the risk of second malignancies after modern radiotherapy.

Authors:  Wayne D Newhauser; Marco Durante
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

Review 8.  Applications of nanodosimetry in particle therapy planning and beyond.

Authors:  Antoni Rucinski; Anna Biernacka; Reinhard Schulte
Journal:  Phys Med Biol       Date:  2021-12-10       Impact factor: 3.609

9.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

10.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation.

Authors:  Thomas Friedrich; Uwe Scholz; Thilo Elsässer; Marco Durante; Michael Scholz
Journal:  J Radiat Res       Date:  2012-12-23       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.